These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23331458)

  • 1. Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions.
    Doumba PP; Nikolopoulou M; Gomatos IP; Konstadoulakis MM; Koskinas J
    BMC Gastroenterol; 2013 Jan; 13():17. PubMed ID: 23331458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class I and class II major histocompatibility complex antigens expression on human hepatocytes and hepatoma cells: an approach with high sensitivity and specificity.
    Chiu JH; Lui WY; Chang HM; Loong CC; Wu LH; Kao HL; Wu CW
    Cytometry; 1997 Dec; 30(6):317-23. PubMed ID: 9440824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two phase kinetics of the inflammatory response from hepatocyte-peripheral blood mononuclear cell interactions.
    Beringer A; Molle J; Bartosch B; Miossec P
    Sci Rep; 2019 Jun; 9(1):8378. PubMed ID: 31182764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury.
    Oda S; Uchida Y; Aleo MD; Koza-Taylor PH; Matsui Y; Hizue M; Marroquin LD; Whritenour J; Uchida E; Yokoi T
    Arch Toxicol; 2021 Jan; 95(1):149-168. PubMed ID: 32816093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.
    Wan YL; Zheng SS; Zhao ZC; Li MW; Jia CK; Zhang H
    World J Gastroenterol; 2004 Jan; 10(2):195-9. PubMed ID: 14716821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.
    Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC
    Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions.
    Wu K; Kryczek I; Chen L; Zou W; Welling TH
    Cancer Res; 2009 Oct; 69(20):8067-75. PubMed ID: 19826049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
    Shimoda M; Tomimaru Y; Charpentier KP; Safran H; Carlson RI; Wands J
    J Hepatol; 2012 May; 56(5):1129-1135. PubMed ID: 22245894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma.
    Montalbano M; Rastellini C; McGuire JT; Prajapati J; Shirafkan A; Vento R; Cicalese L
    Cell Oncol (Dordr); 2018 Apr; 41(2):169-184. PubMed ID: 29204978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elevated Fas expression is related to increased apoptosis of circulating CD8(+)T cell in patients with hepatocellular carcinoma].
    Guo CL; Bi YM; Liu Z; Xu Y; Sun YX; Wang QC
    Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):125-129. PubMed ID: 29804379
    [No Abstract]   [Full Text] [Related]  

  • 12. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of p-STAT3 in peripheral blood CD4+ and CD8+ T cells related to hepatocellular carcinoma development.
    Wang X; Xin W; Zhang H; Zhang F; Gao M; Yuan L; Xu X; Hu X; Zhao M
    Mol Med Rep; 2014 Nov; 10(5):2649-56. PubMed ID: 25175640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of lncRNA NEAT1 enhances the antitumor activity of CD8
    Yan K; Fu Y; Zhu N; Wang Z; Hong JL; Li Y; Li WJ; Zhang HB; Song JH
    Int J Biochem Cell Biol; 2019 May; 110():1-8. PubMed ID: 30710754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
    Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
    Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes.
    Jang JW; Song Y; Kim KM; Kim JS; Choi EK; Kim J; Seo H
    BMC Cancer; 2016 Oct; 16(1):810. PubMed ID: 27756242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-35 Dampens CD8
    Yang L; Shao X; Jia S; Zhang Q; Jin Z
    Front Immunol; 2019; 10():1032. PubMed ID: 31134088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
    Fukuzawa Y; Takahashi K; Furuta K; Tagaya T; Ishikawa T; Wada K; Omoto Y; Koji T; Kakumu S
    J Gastroenterol; 2001 Oct; 36(10):681-8. PubMed ID: 11686478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma.
    Sung CH; Hu CP; Hsu HC; Ng AK; Chou CK; Ting LP; Su TS; Han SH; Chang CM
    J Clin Invest; 1989 Feb; 83(2):421-9. PubMed ID: 2536398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.